Fireside Chat: Differentiating in Crowded Specialty Markets: Strategy, Patient Impact, and Sustainable Growth

Session details:

As specialty markets become more crowded and complex, differentiation requires more than a strong launch alone. This fireside chat will explore how biopharma leaders are adapting strategy to incorporate evolving patient expectations, payer dynamics, and category competition while building momentum for new therapies while sustaining established brands. Using real world examples, the discussion will examine what it takes to create durable impact in specialty markets and what will define success in the next phase of growth.

Conversation to expand on:

• How to differentiate in crowded specialty markets when first-mover advantage is no longer enough
• How the launch and growth playbook is evolving in response to patient expectations, payer pressure, and increasing market complexity
• How leaders can connect unmet need, evidence, and market insights to shape stronger positioning and more durable impact
• How to create momentum for new therapies while continuing to support established brands
• How biosimilars, access dynamics, and category saturation are reshaping the path to sustainable growth in specialty markets
• What will distinguish successful players going forward, from sharper differentiation to stronger cross-functional execution